Previous close | 3.0100 |
Open | 3.0000 |
Bid | 2.8500 |
Ask | 3.4000 |
Strike | 6.00 |
Expiry date | 2024-06-21 |
Day's range | 3.0100 - 3.0100 |
Contract range | N/A |
Volume | |
Open interest | 22 |
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With the business potentially at an important milestone, we thought we'd take a closer look at Heron Therapeutics...
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call and live webcast on Tuesday, May 7, 2024, at 8:30 a.m. ET to report first quarter 2024 financial results and discuss recent business highlights.